WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
1-Year Return
17.41%
This Quarter Return
+6.94%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$310M
AUM Growth
-$281M
(-48%)
Cap. Flow
-$255M
Cap. Flow
% of AUM
-82.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
3
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
+$118M |
| 2 |
Prothena Corp
PRTA
|
+$92.7M |
| 3 |
NCNA
NuCana
NCNA
|
+$22M |
| 4 |
Theravance Biopharma
TBPH
|
+$15.8M |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$6.24M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Theravance Biopharma
TBPH
$720M
| $221M | 71.3% |
11,350,719
-809,261
| -7% | -$15.8M |
|
|
EVFM
2
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $63M | 20.31% |
833,081
-82,508
| -9% | -$6.24M |
|
|
AUTL
3
Autolus Therapeutics
AUTL
$367M
| $26M | 8.39% |
2,095,127
-9,499,107
| -82% | -$118M |
|
|
NCNA
4
NuCana
NCNA
$7.37M
| – | – |
-424
| Closed | -$22M |
|
|
5
Prothena Corp
PRTA
$442M
| – | – |
-8,773,790
| Closed | -$92.7M |
|